Your account is not claimed yet. You can sign up with ORCID to claim your account.

Laurence Fayadat-Dilman

Years Active: 2020-2020
Publications (10 Years): 1

Merck and Co

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Merck and Co

United States

Sr Director :: Protein Sciences

Publications

Beth Hutchins, Gary C Starling, Mark A McCoy, Danuta Herzyk, Frederique M Poulet, John Dulos, Liming Liu, Soonmo Peter Kang, Laurence Fayadat-Dilman, Mark Hsieh, Christine L Andrews, Gulesi Ayanoglu, Constance Cullen, Rene de Waal Malefyt, Robert A Kastelein, Sabine Le Saux, Julie Lee, Sophie Li, Dan Malashock, Svetlana Sadekova, Gregory J Carven, Hans van Eenennaam, Aarron Willingham, Ying Yu, Michel Streuli, Andrea van Elsas
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab. Molecular cancer therapeutics 19 (6) (2020)

Laurence Fayadat-Dilman.css-eqlu8i{font-size:small;padding-left:4px;}